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Aim—To examine the association of dietary fiber intake with inflammation and arterial stiffness
among youth with type 1 diabetes (T1D) in the US.
Methods—Data are from youth ≥ 10 years old with clinically diagnosed T1D for ≥ 3 months and
≥ 1 positive diabetes autoantibody in the SEARCH for Diabetes in Youth Study. Fiber intake was
assessed by food frequency questionnaire with measurement error (ME) accounted for by
structural sub-models derived using additional 24-hour dietary recall data in a calibration sample
and the respective exposure-disease model covariates. Markers of inflammation, measured at
baseline, included IL-6 (n=1405), CRP (n=1387), and fibrinogen (n=1340); markers of arterial
stiffness, measured approximately 19 months post-baseline, were available in a subset of
participants and included augmentation index (n=180), pulse wave velocity (n=184), and brachial
distensibility (n=177).
Results—Mean (SD) T1D duration was 47.9 (43.2) months; 12.5% of participants were obese.
Mean (SD) ME-adjusted fiber intake was 15 (2.8) g/day. In multivariable analyses, fiber intake
was not associated with inflammation or arterial stiffness.
Conclusion—Among youth with T1D, fiber intake does not meet recommendations and is not
associated with measures of systemic inflammation or vascular stiffness. Further research is
needed to evaluate whether fiber is associated with these outcomes in older individuals with T1D
or among individuals with higher intakes than those observed in the present study.
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Introduction
A high-fiber diet may be protective against inflammation, which plays a key role in the
development of atherosclerosis and subsequent vascular disease. Both observational and
experimental studies among adults have reported an inverse relationship between dietary
fiber and acute-phase inflammatory response markers, including interleukin 6 (IL-6) [1,2]
and C-reactive protein (CRP) [2-4], and indicators of an abnormal prothrombotic state, such
as fibrinogen [5,6]. Two recent studies among adolescents have also supported an inverse
relationship between fiber intake and inflammation [7,8].
A more limited literature exists on the relationship between dietary fiber and measures of
subclinical vascular disease. An Australian study among overweight and obese adults
showed a decrease in augmentation index (AIx), a measure of central vascular function, after
6 weeks on a fiber supplement relative to placebo [9], and a longitudinal observational study
among adolescents and young adults in the Netherlands reported an inverse association
between fiber intake and carotid artery distensibility [10].
Patients with type 1 diabetes (T1D) are at increased risk of cardiovascular disease (CVD):
coronary heart disease occurs earlier and is associated with higher mortality among these
individuals [11]. Indeed, decreased carotid artery distensibility [12,13] and brachial
distensibility [14], and increased AIx [15] and carotid artery intima-media thickness [13,16]
have been reported in children and adolescents with T1D. While dietary fiber has been
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linked to improved postprandial glycemia [17,18] and total cholesterol [19] among
individuals with T1D, a potential protective effect of fiber on inflammation and subclinical
vascular disease, particularly among youth, has yet to be confirmed. One observational study
among adults with T1D reported an inverse association between dietary fiber intake and
low-grade inflammation, quantified as an overall z-score of IL-6, CRP, and tumor necrosis
factor α levels [20]. To our knowledge, only a single experimental study, conducted in
1981, has explored this relationship in youth with T1D, reporting a decrease in fibrinogen
after 4 weeks on a diet supplemented with 0.45 g guar gum/kg body weight/day [21]. If a
protective effect of high-fiber diets on inflammation and subclinical vascular disease indeed
exists, it would represent an important opportunity for early intervention to reduce CVD risk
in this population. To address this gap in scientific knowledge, we evaluated the association
of dietary fiber with inflammation and arterial stiffness among youth with T1D.
Methods
Study Population
Data are from SEARCH for Diabetes in Youth [22], which includes a cohort of youth
diagnosed with diabetes at < 20 years of age across 5 sites in the U.S. beginning in 2002. In
2001, prevalent cases were also identified. Participants were asked to complete an initial
survey and after completion were invited for an initial study visit. Participants in the
prevalent 2001 and incident 2002-2005 cohorts who completed the dietary intake assessment
(restricted to those ≥ 10 years old) and had ≥ 1 inflammatory marker measured during this
initial study visit, had a diabetes duration ≥ 3 months, were positive for ≥ 1 diabetes
autoantibody (GAD65 and IA2), and had a complete covariate set were included in this
analysis. The final sample size was 1405. Study protocols were approved by Institutional
Review Boards at all participating sites, and written informed consent was obtained for all
participants ≥ 18 years of age and parent/guardian permission and participant assent for
participants < 18 years of age.
Dietary Intake Assessment
A modified version of the Block Kid's Food Frequency Questionnaire (FFQ) was used to
assess dietary intake in SEARCH participants ≥ 10 years of age during the initial study visit
[23]. The FFQ included approximately 85 food items for which information on consumption
in the past week (“yes” or “no”) was collected. For participants responding “yes”, additional
data on how many days in the past week the item was consumed and typical portion size
were collected. The nutrient and portion-size databases were established using the Nutrition
Data System for Research (Database 3, Version 4.05/33, 2002, Nutrition Coordinating
Center, University of Minnesota, Minneapolis, Minnesota) and industry sources.
In order to address measurement error (ME) associated with the FFQ, a Dietary Assessment
Calibration Subsample was conducted in the SEARCH Nutrition Ancillary Study that
included 172 participants who completed the FFQ and then completed up to three 24-hour
dietary recalls over the course of the following 30 days. From these data, models were
constructed to predict 24-hour dietary recall intake (assumed to be unbiased) from intake
assessed by FFQ and the respective exposure-disease model covariates. The application of
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this method has been discussed in detail elsewhere [24]. Because the inflammatory markers,
AIx, and carotid-femoral pulse wave velocity (PWV) and brachial artery distensibility
(BrachD) exposure-disease models had three different covariate sets, three ME-adjustment
models were constructed. Based on the relationships estimated by these models, total energy
(kcal/day) and fiber intake (g/day) in the SEARCH sample were predicted and these ME-
adjusted dietary intakes were used in their respective exposure-disease models.
Given that this is a sample of children and adolescents, and that fiber recommendations are
given in units of g/1000 kcal [25], for descriptive purposes participant characteristics were
presented according to quartiles of ME-adjusted fiber in units of g/1000 kcal. The quartile
cut points predicted using the inflammatory marker covariate set were used given that these
quartile cut points were equivalent to those predicted by the PWV/BrachD covariate set and
differed by only a tenth of a gram from those predicted by the AIx covariate set. All
exposure-disease models specified ME-adjusted fiber in units of g/day (quartiles or
continuous), controlling for ME-adjusted total energy intake (kcal/day).
Outcome Assessment
During the initial study visit, a fasting venipuncture was performed on metabolically stable
participants, defined as no episode of diabetic ketoacidosis in the past month. Three
inflammatory markers—IL-6, CRP, and fibrinogen—were analyzed in stored samples from
this visit at the study Central Laboratory (Northwest Lipid Metabolism and Diabetes
Research Laboratories, University of Washington, Seattle, Washington). Specifically, IL-6
was assayed using the Human Adipokine panel B (Millipore Inc., Billerica, Massachusetts)
on a Bio-Plex suspension array system (Bio-Rad Laboratories, Hercules, California), and
CRP and fibrinogen were analyzed using Siemens reagent on a Siemens BNII nephelometer
(Siemens Healthcare Diagnostics Inc., Newark, Delaware).
As part of a pilot study on CVD, measures of arterial stiffness were also collected on a
subset of participants at two SEARCH sites. This CVD pilot study visit took place, on
average, 19.4 ± 7.6 months after the SEARCH initial study visit. BrachD, a measure of
vascular function of a peripheral muscular artery, was measured using a DynaPulse Pathway
instrument (Pulse Metric, Inc., San Diego, California). PWV, a measure of pulse
propagation representing central arterial stiffness, and AIx, a measure of wave reflections,
were assessed using a SphygomCor SCOR-PVx System (Atcor Medical, Sydney, Australia)
[14]. AIx was normalized to a heart rate of 75 beats per minute and expressed as a percent
(AIx-75).
Covariate Assessment
Self-reported demographic covariates included gender, race/ethnicity, and estimated total
annual household income. Smoking and physical activity questions were derived from the
national Youth Risk Behavior Survey [26]. Participants were classified as “Current
smokers” if they self-reported having smoked cigarettes on at least one of the 30 days
preceding the survey; “Past smokers” if they had tried smoking or had smoked regularly (at
least one cigarette every day for 30 days) but were not current smokers; and “Never
smokers” if they had never smoked a whole cigarette. Participants who self-reported
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participating in physical activity that made them breathe hard or sweat for at least 20
minutes, on average, 0-2 days per week were classified as “Physically inactive”; and 3-7
days per week as “Physically active”.
Body mass index (BMI) was calculated as measured weight (kg) divided by height squared
(m2), and obesity was defined as a BMI ≥ 95th age- and sex-specific percentile for
participants ≤ 20 years of age and BMI ≥ 30 kg/m2 for participants > 20 years of age [27].
Systolic and diastolic blood pressure (SBP and DBP, respectively) were measured using a
standard mercury sphygmomanometer in triplicate and the average was used in subsequent
analyses.
Statistical Analysis
Log transformations were used to account for non-normality of the exposures (ME-adjusted
energy and fiber intake) and the inflammatory marker outcomes (IL-6, CRP, and
fibrinogen). Multivariable linear regression models were used to estimate the association of
ME-adjusted dietary fiber intake with inflammation and arterial stiffness. Potential
confounders were identified through a literature review and formally evaluated by assessing
their relationships with the exposure and outcomes. The final adjustment set included ME-
adjusted total energy intake, age, gender, race/ethnicity, diabetes duration, smoking status,
and physical activity. Models predicting the arterial stiffness outcomes (PWV, AIx-75, and
BrachD) were additionally adjusted for the time between assessment of diet (SEARCH
initial study visit) and arterial stiffness (CVD pilot study visit), and mean arterial blood
pressure (to account for background distending pressure) calculated as [(2 × DBP) + SBP]
divided by 3. Models predicting AIx-75 were also adjusted for height given that height
directly influences the distance from the heart of wave reflection sites. As a sensitivity
analysis, exposure-disease models stratified by soluble and insoluble fiber intake were also
explored. All analyses were conducted using SAS 9.2 (SAS Institute, Cary, North Carolina).
Values are presented as mean ± SD or %.
Results
Participants were 14.7 ± 3.0 years of age with a diabetes duration of 47.9 ± 43.2 months;
50.5% of participants were female (Table 1). The BMI-z score was 0.64 ± 0.89; 12.5% of
participants were classified as obese. Estimated total dietary fiber from the SEARCH FFQ
was 13.6 ± 7.1 g/day. Fiber intake was 14.7 ± 2.8 g/day as predicted by the ME model
applied to the inflammatory maker covariate set; 14.5 ± 2.8 g/day for that applied to the AIx
covariate set; and 14.5 ± 2.8 g/day for that applied to the PWV and BrachD covariate set.
Participants who were female, older, had shorter diabetes durations, had never smoked or
were former smokers, and who exercised 3-7 days/week were more likely to be in the
highest versus lowest quartile of ME-adjusted fiber intake (Table 1). There were no
differences in race/ethnicity, BMI-z score, SBP, or DBP across dietary fiber quartiles and no
clear association with obesity status was observed.
Mean unadjusted levels of markers of inflammation and arterial stiffness did not differ
across quartiles of ME-adjusted dietary fiber intake (Table 1). Controlling for confounding
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factors, multivariable linear regression models confirmed that ME-adjusted dietary fiber
intake was not associated with markers of inflammation or arterial stiffness in this sample.
This observation held true when fiber intake was specified as quartiles (Table 2; Model 1) or
continuously (Table 2; Model 2).
When dietary fiber was stratified by solubility, though parameter estimates for soluble fiber
intake were larger than those for insoluble fiber intake, effects remained nonsignificant (data
not shown).
Discussion
No association was observed between dietary fiber intake and markers of inflammation or
arterial stiffness among youth with T1D. While these results are in contrast with the
preponderance of evidence relating to IL-6 and CRP among adults and adolescents without
diabetes [1-4], the evidence remains mixed for fibrinogen. In the National Heart, Lung, and
Blood Institute Family Heart Study, no association was observed between dietary fiber and
fibrinogen [28]. A randomized crossover study among healthy adults did not find a
difference at 4 weeks in fibrinogen between diets supplemented with cereal fiber (19 g/day)
and control diets [29], and a parallel randomized controlled trial among overweight and
obese adults reported no differences in IL-6, CRP, or fibrinogen at 3 months between diets
supplemented with psyllium (7 or 14 g/day) compared to control diets [30]. Indeed, null
results relating to the fiber-CRP relationship among adults have also been reported [2,31].
We suggest three primary hypotheses to explain these conflicting results: differences in 1)
fiber dose, 2) fiber type, and 3) sample population.
Fiber dose
An important advantage of epidemiological studies is that they provide a “reality check” on
whether exposures are occurring in the population such that one could anticipate the health
benefits reported in clinical trials. Our results confirm that youth with T1D have low dietary
fiber intakes relative to the current American Diabetes Association (ADA) recommendation
of 14 g/1000 kcal [25]; in fact, the average dietary fiber intake was about half of what is
recommended. Further, the dietary fiber intakes previously reported to have a protective
effect against low-grade inflammation, CVD, and all-cause mortality among adults with
T1D were substantially higher than the intakes in our sample population [20,32]. Our study
therefore suggests that current fiber intakes of youth with T1D in the US may not be high
enough to observe the previously reported protective effects of this nutrient.
Fiber type
Some studies have shown a stronger protective effect for soluble fiber compared to insoluble
fiber [20,32]. However, our results remained non-significant when stratified by fiber
solubility. Future research should explore the effects of specific types of fiber, considering
not only solubility in water, but also microbial fermentation in the large intestine and
viscosity, which may influence fiber action. Although the mechanisms underlying the
potential beneficial effects of dietary fiber on proinflammatory and prothrombotic states
have not been fully elucidated, a leading hypothesis involves the production of short-chain
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fatty acids from fermentable dietary fiber in the gut. For example, butyrate inhibits the effect
of nuclear factor-κB, resulting in an overall decrease in the proinflammatory state [33], and
acetate and propionate reduce IL-6 mRNA and proteins [34]. Dietary fibers, such as β-
glucans, may also interact directly with immunoregulatory cells, resulting in anti-
inflammatory phenotypes [35]. The mechanisms underlying a potential protective effect of
dietary fiber on endothelial function have yet to be explored, but may be related to observed
improvements in blood pressure, lipid profiles, and inflammation. In summary, though
several biological mechanisms of specific fiber types have been explored, the mechanisms
underlying previously observed inverse relationships between dietary fiber intake and
inflammation and arterial stiffness are not well understood.
Sample population
To our knowledge, this is the first observational study to evaluate the association of dietary
fiber with inflammation and arterial stiffness among youth with T1D. A recent observational
study among 559 adolescents without T1D reported that dietary fiber intake was inversely
associated with CRP and fibrinogen [8], but the levels of CRP and fibrinogen in their
population were lower than those seen in our sample. The observed protective effect in their
study was also of note given that the reported fiber intake was lower in their population
compared to our sample. One explanation for these observations is that the higher level of
systemic inflammation seen in adolescents with T1D may indicate that in this population
there are factors with stronger causal effects on inflammation than dietary fiber, and this
may mask any beneficial effects. Other study populations reporting protective effects of
fiber on inflammation have included European adults with T1D (median disease duration of
14.4 years) in the EURODIAB cohort [20] and US adults in the NHANES cohort [3]. The
variability in reported results from these diverse populations further justifies the need for
population-specific research of the potential beneficial effects of dietary fiber on CVD risk.
A key strength of this analysis is the inclusion of multiple measurements of the outcomes of
interest. Previous studies have focused on a single inflammatory marker, most frequently
CRP due to its stability and ease of measurement. These CVD risk factors may be more
strongly correlated with adverse outcomes compared to traditional risk factors, such as BMI.
Another strength of this study was the inclusion of measures of arterial stiffness, an early
marker of the development of vascular disease and therefore an important intervention point.
Additionally, we used innovative methods to account for the ME associated with the FFQ,
and therefore our estimates of fiber and energy intake are likely less biased than those
reported in previous studies.
A limitation of this analysis is the potential for residual systematic error in estimated fiber
intake that remains after ME-adjustment. Furthermore, we only had measures of the
outcomes at a single timepoint (baseline for the inflammatory markers and approximately 19
months post-baseline for the arterial stiffness markers). The samples sizes, particularly for
the measures of arterial stiffness, were small and therefore null findings may indicate a lack
of power to detect an effect. Future analyses of the ongoing SEARCH Cohort Study will
allow both longitudinal analyses and evaluation of the association with subclinical measures
of vascular disease in a larger sample. However, the analysis presented here represents the
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best available evidence on the relationship between dietary fiber and markers of early
vascular disease development in youth with T1D.
The low dietary fiber intakes observed among youth with T1D in the US are not associated
with measures of systemic inflammation or vascular stiffness. Clinical and public health
efforts should focus on increasing these disconcertingly low dietary fiber intakes to meet
current recommendations. Future research should involve clinical trials exploring feasible
doses among youth with T1D and prospective observational studies in adults with longer
T1D durations.
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